Immobilized HLA-G&B2M&Peptide (RIIPRHLQL) Monomer[Biotin], His & Avi, Human, His Tag at 1 μg/ml (100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-HLA-G Antibody, hFc Tag with the EC50 of 4.6 ng/ml determined by ELISA.
The purity of HLA-G&B2M&Peptide (RIIPRHLQL) Monomer[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.
HLA-G&B2M&Peptide (RIIPRHLQL) Monomer[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
HLA-G&B2M&Peptide (RIIPRHLQL) Monomer[Biotin], His & Avi, Human
HLA-G is a molecule that was first known to confer protection to the fetus from destruction by the immune system of its mother, thus critically contributing to fetal-maternal tolerance. The first functional finding constituted the basis for HLA-G research and can be summarized as such: HLA-G, membrane-bound or soluble, strongly binds its inhibitory receptors on immune cells (NK, T, B, monocytes/dendritic cells), inhibits the functions of these effectors, and so induces immune inhibition.
| Z06513 | |
|
|
|
| ¥95,137.00 | |
|
|
|
|
|
|
| Ask us a question | |
